Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2020. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3789098013 | Product containing only caplacizumab (medicinal product) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 3789099017 | Caplacizumab only product | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 2828071000001115 | Caplacizumab (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
| 2828081000001118 | Caplacizumab | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Caplacizumab | Is a | Product containing caplacizumab (medicinal product) | true | Inferred relationship | Existential restriction modifier | ||
| Caplacizumab | Has active ingredient | Caplacizumab | true | Inferred relationship | Existential restriction modifier | 1 | |
| Caplacizumab | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Caplacizumab | Is a | Virtual therapeutic moiety | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing only caplacizumab in parenteral dose form (medicinal product form) | Is a | True | Caplacizumab | Inferred relationship | Existential restriction modifier | |
| Caplacizumab 10mg powder and solvent for solution for injection vials | Is a | True | Caplacizumab | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR